Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02484339
What this trial is testing

Treatment of Advanced Castration Resistant Prostate Carcinoma With Limited Bone Metastases (α-RT)

Who this might be right for
Prostate Carcinoma
University Hospital Freiburg 274
Large-scale testing (Phase 3)Ended earlyNCT00005075
What this trial is testing

Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
EDAP Technomed
Testing effectiveness (Phase 2)Study completedNCT00384839
What this trial is testing

Vidaza to Restore Hormone Thx Prostate

Who this might be right for
Prostate Cancer
US Oncology Research 36
Testing effectiveness (Phase 2)Study completedNCT02125357
What this trial is testing

Sequencing Abiraterone and Enzalutamide in mCRPC

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
British Columbia Cancer Agency 202
Testing effectiveness (Phase 2)Ended earlyNCT03741712
What this trial is testing

SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPC

Who this might be right for
Prostate CancerCastration-resistant Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 9
Testing effectiveness (Phase 2)Study completedNCT01718353
What this trial is testing

Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer Metastatic
Sanofi 63
Testing effectiveness (Phase 2)Study completedNCT00004043
What this trial is testing

Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 25
Testing effectiveness (Phase 2)Study completedNCT00345813
What this trial is testing

Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Wake Forest University Health Sciences 62
Testing effectiveness (Phase 2)Study completedNCT01078662
What this trial is testing

Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats

Who this might be right for
OvarianBreastProstate+2 more
AstraZeneca 298
Testing effectiveness (Phase 2)UnknownNCT01890096
What this trial is testing

A Phase II Trial of High Dose-Rate Brachytherapy as Monotherapy in Low and Intermediate Risk Prostate Cancer

Who this might be right for
Carcinoma of the Prostate
Sunnybrook Health Sciences Centre 174
Not applicableStudy completedNCT06016725
What this trial is testing

Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF Trial

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+6 more
Ohio State University Comprehensive Cancer Center 75
Testing effectiveness (Phase 2)UnknownNCT01685190
What this trial is testing

Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Institute of Cancer Research, United Kingdom 124
Not applicableLooking for participantsNCT07790718
What this trial is testing

Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate Cancer

Who this might be right for
Colon PolypColorectal CarcinomaLocalized Prostate Carcinoma+3 more
City of Hope Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT01748500
What this trial is testing

Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
University Health Network, Toronto 21
Testing effectiveness (Phase 2)Study completedNCT01009736
What this trial is testing

Effects of Tomato-Soy Juice on Biomarkers in Patients With Prostate Cancer Undergoing Prostatectomy

Who this might be right for
Prostate Cancer
Ohio State University Comprehensive Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT06849544
What this trial is testing

Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection

Who this might be right for
Prostate Cancer SurgeryProstate Cancer Metastatic Disease
Clinton Bahler 22
Testing effectiveness (Phase 2)Study completedNCT00411528
What this trial is testing

Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer

Who this might be right for
Metastatic Hormone Refractory Prostate Cancer
Novartis Pharmaceuticals 185
Testing effectiveness (Phase 2)Study completedNCT02107404
What this trial is testing

Phase II Study of DCVAC/PCa Added After Radical Primary Prostatectomy for Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
SOTIO a.s. 150
Testing effectiveness (Phase 2)Study completedNCT03315871
What this trial is testing

Combination Immunotherapy in Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Looking for participantsNCT06689163
What this trial is testing

The Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone

Who this might be right for
Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 66
Next Page